We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Using information technology (IT) in chronic disease management systems (CDMSs) and electronic medical records (EMRs) offers new ways to combat disease and cut costs, said a new white paper from the California HealthCare Foundation (CHCF).
Device and diagnostics makers can avoid being blamed for inflated healthcare costs by focusing on competitive strategies that add value to their products, experts say.
The House yesterday passed a sweeping health information technology (HIT) bill that includes a provision designed to boost the use of electronic clinical trial data, but the measure came under swift attack by Democrats who charged that it would not improve technology adoption but would endanger the privacy of patient medical records.
Several new products and partnerships in the field of electronic data capture (EDC) were unveiled at the Drug Industry Association’s (DIA) annual conference in Philadelphia in June.
The biotech industry’s push for additional federal stem cell research funding failed July 19 as President Bush used the first veto of his presidency to send the legislation back to likely defeat in Congress.
It is important to know the details of what your firewall needs to accomplish, says consultant Mike Chapple in a white paper sponsored by Villanova University.
Several new products and partnerships in the field of electronic data capture (EDC) were unveiled at the Drug Industry Association’s (DIA) annual conference in Philadelphia in June.
Researchers have found that brain signals from patients with severe, long-term paralysis can be translated through a computer to allow those patients to perform some physical actions.
The FDA has published new guidance on when companies should communicate product information to the public via electronic technologies, such as the internet, and how that information should be formatted.
Based on recommendations of a special task force charged with looking into the growing problem of counterfeit drugs, the FDA says it is now prepared to implement a long-anticipated system for overseeing drug products’ movement throughout the distribution chain.